Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Lexington, MA
SEC filing record 1 source field available
Fiscal year end
31 December
Aldeyra Therapeutics, Inc. has filed 645 SEC EDGAR filings since 06 Oct 2005

SEC filing history

Showing 551-575 of 643 matching filings.

Per page
25
Current page
23
424B1 File 333-203077

FORM 424(B)1

Filing date
07 Apr 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B1 File 333-203078

FORM 424(B)1

Filing date
07 Apr 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1 File 333-203078

FORM S-1

Filing date
27 Mar 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1 File 333-203077

FORM S-1

Filing date
27 Mar 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-203076

FORM S-8

Filing date
27 Mar 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36332

FORM 8-K

Filing date
19 Mar 2015
Reporting date
19 Mar 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36332

FORM 8-K

Filing date
17 Mar 2015
Reporting date
17 Mar 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36332

FORM 8-K

Filing date
13 Mar 2015
Reporting date
11 Mar 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36332

FORM 8-K

Filing date
02 Mar 2015
Reporting date
02 Mar 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-88182

SC 13G/A filing

Filing date
13 Feb 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-88182

SCHEDULE 13G FOR ALDEYRA THERAPEUTICS BY JOHNSON & JOHNSON

Filing date
05 Feb 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
D File 021-233587

D filing

Filing date
05 Feb 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-88182

SCHEDULE 13G FOR ALDEYRA THERAPEUTICS, INC. BY DOMAIN PARTNERS VI, L.P.

Filing date
05 Feb 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
D File 021-233108

D filing

Filing date
29 Jan 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36332

FORM 8-K

Filing date
22 Jan 2015
Reporting date
21 Jan 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36332

8-K

Filing date
20 Jan 2015
Reporting date
20 Jan 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36332

FORM 8-K

Filing date
15 Jan 2015
Reporting date
14 Jan 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36332

8-K

Filing date
13 Jan 2015
Reporting date
12 Jan 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36332

8-K

Filing date
02 Jan 2015
Reporting date
30 Dec 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36332

FORM 8-K

Filing date
18 Dec 2014
Reporting date
18 Dec 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36332

8-K

Filing date
12 Nov 2014
Reporting date
07 Nov 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36332

8-K

Filing date
05 Sep 2014
Reporting date
05 Sep 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36332

FORM 8-K

Filing date
02 Sep 2014
Reporting date
02 Sep 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .